Author
(reference) |
Years |
No.of
case |
Country |
AST |
ALT |
Means±SD
(range) |
abnormality
(%) |
Means±SD
(range) |
abnormality
(%) |
Berman [15] |
1973 |
87 |
South Vienam |
NA |
47.1 |
NA |
NA |
Yang [4] |
1995 |
45 |
Taiwan |
222.9±198.3
(42－862) |
74.5 |
220.3±195.6
(51－732) |
74.5 |
Ogawa [5] |
2002 |
462 |
Japan |
NA |
87 |
NA |
77 |
Park [14] |
2003 |
22 |
Korea |
92.5±11.7
(34－255) |
NA |
93.2±17.3
(18－345) |
NA |
Hu [7] |
2005 |
30 |
Taiwan |
148(median)
(14－461) |
89.3 |
120(median)
(24－538) |
91.7 |
Charoensak
[10] |
2006 |
130 |
Thailand |
NA |
58.5 |
NA |
58.5 |
Wie [11] |
2008 |
212 |
Korea |
93±86 |
93.4 |
86±84 |
93.4 |
Huang [12] |
2009 |
28 |
Taiwan |
NA |
100 |
NA |
91.3 |
Kim [8] |
2010 |
89 |
Korea
(severe)* |
100.9±77.3 |
88.8 |
75.0±74.4 |
94.4 |
|
|
119 |
Korea
(non-severe) |
104.1±86.8 |
90.8 |
91.2±86.5 |
89.1 |
Lee [9] |
2010 |
84 |
Korea
(Group I)** |
121.60±85.95 |
NA |
107.35±168.92 |
NA |
|
|
162 |
Korea
(Group II) |
106.87±99.44 |
NA |
97.15±103.94 |
NA |
Note: AST: aspartate transaminase; ALT; alanine transaminase; SD, standard deviation; NA: none analysis.
*severe cases indicate patients with complications, including pneumonia, renal failure, meningoencephalitis, myocariditis, GI bleeding, shock, or death.
**Group I indicates patients with albumin < 3.0 mg/dL; Group II indicates patients with albumin ≥3.0mg/dL. |
